# Carlyle Group Inc.: overview

CG · Nasdaq · CIK 1527166 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cg.md) · [Financials](/companies/cg/financials.md) · [Filings](/companies/cg/filings.md) · [Insiders](/companies/cg/insiders.md)

Latest reported revenue: [$1.12bn](/filings/0001527166-26-000045.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:Revenues, accession 0001527166-26-000045).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,635](/filings/0001527166-25-000125.md) | [1,033 d](/filings/0001527166-26-000009.md) | [973](/filings/0001527166-26-000027.md) | [1,573](/filings/0001527166-26-000045.md) | [333](/filings/0001527166-25-000125.md) | [1,901 d](/filings/0001527166-26-000009.md) | [254](/filings/0001527166-26-000027.md) | [1,124](/filings/0001527166-26-000045.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [22.6%](/filings/0001527166-25-000125.md) | [20.4% d](/filings/0001527166-26-000009.md) | [13.4%](/filings/0001527166-26-000027.md) | [20.3%](/filings/0001527166-26-000045.md) | [0.3%](/filings/0001527166-25-000125.md) | [18.8% d](/filings/0001527166-26-000009.md) | [(52.0%)](/filings/0001527166-26-000027.md) | [12.2%](/filings/0001527166-26-000045.md) |
| Diluted EPS | $ per share | [1.63](/filings/0001527166-25-000125.md) | not reported | [0.35](/filings/0001527166-26-000027.md) | [0.87](/filings/0001527166-26-000045.md) | [0.00](/filings/0001527166-25-000125.md) | not reported | [(0.37)](/filings/0001527166-26-000027.md) | [0.37](/filings/0001527166-26-000045.md) |
| Free cash flow | $m | [773 d](/filings/0001527166-25-000125.md) | [(380) d](/filings/0001527166-26-000009.md) | [(369)](/filings/0001527166-26-000027.md) | [(186) d](/filings/0001527166-26-000045.md) | [(1,583) d](/filings/0001527166-25-000125.md) | [(1,237) d](/filings/0001527166-26-000009.md) | [(1,271)](/filings/0001527166-26-000027.md) | [(32.5) d](/filings/0001527166-26-000045.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8,782](/filings/0001527166-24-000019.md) | [4,439](/filings/0001527166-25-000006.md) | [2,964](/filings/0001527166-26-000009.md) | [5,426](/filings/0001527166-26-000009.md) | [4,780](/filings/0001527166-26-000009.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [33.9%](/filings/0001527166-24-000019.md) | [27.6%](/filings/0001527166-25-000006.md) | [(20.5%)](/filings/0001527166-26-000009.md) | [18.8%](/filings/0001527166-26-000009.md) | [16.9%](/filings/0001527166-26-000009.md) |
| Diluted EPS | $ per share | [8.20](/filings/0001527166-24-000019.md) | [3.35](/filings/0001527166-25-000006.md) | [(1.68)](/filings/0001527166-26-000009.md) | [2.77](/filings/0001527166-26-000009.md) | [2.18](/filings/0001527166-26-000009.md) |
| Free cash flow | $m | [1,750](/filings/0001527166-24-000019.md) | [(420)](/filings/0001527166-25-000006.md) | [138](/filings/0001527166-26-000009.md) | [(837)](/filings/0001527166-26-000009.md) | [(3,375)](/filings/0001527166-26-000009.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cg/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.35bn | 31,984,053 |  | Added +959,608 |
| [HARRIS ASSOCIATES L P](/funds/813917.md) | 2026-06-30 | $743.7m | 17,661,625 |  | Added +1,077,718 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $498.2m | 11,830,112 |  | Added +10,562 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $497.5m | 11,813,798 |  | Reduced −6,013,418 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $482.8m | 11,464,474 |  | Added +70,803 |
| [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $421.1m | 10,000,000 | Call | Added +8,550,000 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $420.8m | 9,993,408 |  | Reduced −179,037 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $416.6m | 9,891,982 |  | Added +211,112 |
| [MASSACHUSETTS FINANCIAL SERVICES CO /MA/](/funds/912938.md) | 2026-06-30 | $328.6m | 7,739,524 |  | Added +90,515 |
| [ALKEON CAPITAL MANAGEMENT LLC](/funds/1230239.md) | 2026-06-30 | $250.2m | 5,941,316 |  | Unchanged |

## Recent filings

[All 1,278 filings](/companies/cg/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-10 | 18:05 ET | [10-Q](/filings/0001527166-26-000045.md) | Quarterly report, period 2026-06-30 | 0001527166-26-000045 |
| 2026-08-05 | 21:46 ET | [8-K](/filings/0001527166-26-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001527166-26-000036 |
| 2026-06-05 | 20:30 ET | [8-K](/filings/0001527166-26-000033.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001527166-26-000033 |
| 2026-06-01 | 12:00 ET | [8-K](/filings/0001527166-26-000030.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001527166-26-000030 |
| 2026-05-08 | 20:11 ET | [10-Q](/filings/0001527166-26-000027.md) | Quarterly report, period 2026-03-31 | 0001527166-26-000027 |
| 2026-05-07 | 21:49 ET | [8-K](/filings/0001527166-26-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001527166-26-000023 |
| 2026-04-23 | 20:08 ET | [DEF 14A](/filings/0001527166-26-000017.md) | Proxy statement, period 2026-04-23 | 0001527166-26-000017 |
| 2026-02-27 | 21:13 ET | [10-K](/filings/0001527166-26-000009.md) | Annual report, period 2025-12-31 | 0001527166-26-000009 |
| 2026-02-26 | 12:00 ET | [8-K](/filings/0001527166-26-000006.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001527166-26-000006 |
| 2026-02-18 | 22:29 ET | [SCHEDULE 13D/A](/filings/0001493152-26-007366.md) | Ownership report, active investor, amended | 0001493152-26-007366 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001527166-26-000009.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/7ce9e80f-f504-40ad-b1c2-1632c78fe3fa)

## About the filer

- CIK: 1527166
- Tickers: CG, CGABL
- Exchange: Nasdaq
- SIC code: 6282 Investment Advice
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.